PerkinElmer debuts Clarus Nova GC
- PerkinElmer launched its Clarus Nova gas chromatograph at Analytica 2026 on March 24, pitching a re-engineered GC platform for higher-throughput routine labs. - The standout feature is Dual Simultaneous Injection, which lets labs run two analyses in parallel, alongside faster oven cycles and hydrogen-ready gas controls. - That matters because GC buyers increasingly want fewer bottlenecks, lower helium and energy costs, and easier training in shorthanded regulated labs.
Gas chromatography is one of those lab workhorses that nobody notices until it becomes the bottleneck. It sits in environmental testing, petrochemicals, food, and pharma QA — and when sample queues pile up, everything downstream slows. That is the backdrop for PerkinElmer’s Clarus Nova GC, which the company introduced at Analytica 2026 in Munich on March 24. The pitch is simple: keep the familiar GC workflow, but remove the parts that waste time, gas, and operator attention. (perkinelmer.com) ### What is Clarus Nova, exactly? Clarus Nova is PerkinElmer’s new gas chromatograph platform, and the branding matters more than it sounds. The company is bringing its GC line back under the long-running Clarus name, but with a redesigned system aimed at modern routine labs rather than just replacing an old box with a slightly newer one. PerkinElmer is positioning it for environmental, petrochemical, pharmaceutical, food, and industrial work. (perkinelmer.com) ### What problem is it trying to solve? Basically, three things keep showing up in routine GC labs: sample backlogs, narrow method coverage, and a shortage of experienced operators. A lot of labs do not need a revolutionary measurement principle. They need a machine that starts faster, runs more samples per shift, and does not require a power user every time something drifts out of spec. That is the gap Clarus Nova is aimed at. (perkinelmer.com) ### What is the big technical hook? The most concrete differentiator is Dual Simultaneous Injection, or DSI. That lets a lab run two analyses in parallel within one workflow, which is a direct throughput play. PerkinElmer is also highlighting SWAFER technology for column switching and more complex method setups without forcing the lab to buy a second instrument. In plain English — one system is supposed to cover more jobs and do them faster. (perkinelmer.com) ### Why do faster ovens matter so much? In GC, the oven is the metronome. Heat the column up, cool it down, do it again — over and over. If heating and cooling are faster, the whole cycle time drops, and that can matter more than a flashy detector spec in high-volume labs. PerkinElmer says Clarus Nova uses a high-speed oven plus rapid heating and(perkinelmer.com 1)(perkinelmer.com 2) ### Why is hydrogen all over this launch? Because helium is expensive, supply can be annoying, and labs want alternatives. Clarus Nova is designed to support hydrogen carrier gas, with hydrogen sensors, leak detection, and automatic shutdown protections built in. The catch is that hydrogen only helps if labs feel safe using it, so PerkinElmer is selling cost reduction and safety as a package rather than as separate features. (perkinelmer.com) ### What about training and service? This is where the product is trying to win the operations team, not just the instrument buyer. PerkinElmer says the system uses SimplicityChrom software, guided notifications, predictive maintenance alerts, and tool-free components to reduce training time and shorten service interruptions. That matters because a GC that is easy to restart after a small problem is often more valuable than one with slightly better peak specs on paper. (perkinelmer.com) ### Does this change the aftermarket picture? Potentially, yes. A new GC platform does not just sell the instrument — it can pull through autosamplers, columns, inlet consumables, detectors, maintenance kits, gas-handling parts, and service contracts. If Clarus Nova lands well in routine labs, demand can shift toward the consumables and support e(perkinelmer.com)rom how GC fleets are usually bought and maintained, but it is the commercially important part. (perkinelmer.com) ### Bottom line? This is not a moonshot instrument launch. It is a workflow launch. PerkinElmer is betting that GC buyers in 2026 care less about novelty than about throughput, gas cost, uptime, and getting newer staff productive fast. If that bet is right, Clarus Nova could matter less as a shiny new chromatograph and more as a platform labs actually standardize on.